The International Birnstiel Award for Doctoral Research in Molecular Life Sciences is inviting nominations for its 2020 call. Deadline is 30 June.
New work published in Nature Cell Biology from an international team led by Dr. Michael Borg, a postdoc in the lab of Dr. Frederic Berger at the GMI…
Valneva reported its first quarter financial results ending March 31, 2020.
Read more
Valneva and Instituto Butantan, producer of immunobiologic products, today announced the signing of a binding term sheet for the development,…
Valneva, a specialty vaccine company, and Pfizer Inc. today announced a collaboration to develop and commercialize Valneva’s Lyme disease vaccine…
We are happy to announce that the VBCF has got a new shareholder, the University of Vienna. This new liaison will open up new opportunities for…
Valneva and Dynavax Technologies Corporation announced their collaboration to initiate a vaccine program for the current coronavirus, COVID-19.
Austrian biotech company Calyxha Biotechnologies GmbH announced the grant of European Patent No. EP3383381.
The Austrian biotech incubator and accelerator CEBINA GmbH announces the initiation of several collaborative projects that address the global health…
We thank Michael Krebs, the long-term member of the VBCF supervisory board, for his engagement in VBCF’s development and his invaluable contribution…
The VBCF is a proud member of the VCDI - Vienna COVID-19 Diagnostic Initiative
The COVID-19 pandemic poses an enormous threat for healthcare systems and economies in Austria, Europe and the world. In this time of crisis,…
